🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective was: \- to assess the bioequivalence of a single dos...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2014-09
Trial ID
NCT02237508
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
The purpose of this study is to determine whether Symbicort dosed according...
Status
Completed
Location
Research Site
Start Date
2004-12
Trial ID
NCT00252863
Treatments Being Tested
The purpose of this study is to evaluate the site and mechanisms responsibl...
Status
Recruiting
Location
Arthur F Gelb Medical Corporation
Start Date
2007-10
Trial ID
NCT01225913
This is a randomized, multi-center, active-controlled, repeated measures de...
Status
Completed
Location
3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa
Start Date
2016-04
Trial ID
NCT02757209
This study is conducted to assess whether training participants on proper u...
Status
Completed
Location
Teva Investigational Site 34092
Start Date
2014-05-28
Trial ID
NCT02062463
The objective of this pivotal study is to evaluate the relative bioavailabi...
Status
Completed
Location
Clinical Pharmacology Unit of Mackay Memorial Hospital Tamshui Branch
Start Date
2017-06-19
Trial ID
NCT04494321
Treatments Being Tested
Study comparing the same drugs as a dual combination product (budesonide an...
Status
Completed
Location
Research Site
Start Date
2019-09-10
Trial ID
NCT04078126
Treatments Being Tested
The primary objective of the study is to compare the tolerability of Symbic...
Status
Completed
Location
Research Site
Start Date
2009-01
Trial ID
NCT00837967
Treatments Being Tested
This is a prospective study. It enrolls subjects with allergic rhinitis, wi...
Status
Not Yet Recruiting
Location
Huiying Wang
Start Date
2025-08
Trial ID
NCT07114107